| 1 |
What is the primary function of AI in the medical imaging industry?
|
To conduct medical research |
|
It is anticipated that the adoption of AI technology in the medical imaging industry will be a paradigm shifting trend which will radically increase the speed, quality, and value of work done by healthcare professionals |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review
https://doi.org/10.1016/j.artmed.2023.102698 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
Hence, AI promises to be a valuable tool in addressing the systemic issues of increasing diagnostic imaging workloads and human error which threaten to compromise the quality of care provided by healthcare professionals in medical imaging contexts |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review
https://doi.org/10.1016/j.artmed.2023.102698 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
The factors identified in this review suggest that existing theoretical frameworks used to study AI acceptability need to be modified to better capture the nuances of AI deployment in healthcare contexts where the user is a healthcare professional influenced by expert knowledge and disciplinary norms. Increasing AI acceptability among medical professionals will critically require designing human-centred AI systems which go beyond high algorithmic performance to consider accessibility to users with varying degrees of AI literacy, |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review
https://doi.org/10.1016/j.artmed.2023.102698 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
These include: user factors (individual end user characteristics) involving trust, system understanding, AI literacy, technology receptiveness; system usage factors (human-computer interaction and user experience concerns) entailing value proposition, self-efficacy, burden, and workflow integration; and socio-organisational-cultural factors (contextual and environmental matters) encompassing social influence, organisational readiness, ethicality, and perceived threat. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review
https://doi.org/10.1016/j.artmed.2023.102698 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
The extent to which healthcare professionals perceive that their use of AI is expected and encouraged by influencing agents important to them (e.g. colleagues, department heads, management) |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review
https://doi.org/10.1016/j.artmed.2023.102698 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
The extent to which healthcare professionals perceive AI as threatening their professional role at an individual and industry level compared to being an empowering tool that enables them to be better healthcare professionals |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review
https://doi.org/10.1016/j.artmed.2023.102698 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Ensuring AI systems have high algorithmic performance |
|
The sudden recent increase in papers however suggests interest in AI usage within the healthcare imaging industry is swiftly gaining momentum as the level of technical performance becomes increasingly suitable for medical use, as the market and regulatory landscape gradually consolidates, and as evidence for the applications and benefits of AI become more convincing |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review
https://doi.org/10.1016/j.artmed.2023.102698 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
system usage factors (human-computer interaction and user experience concerns) entailing value proposition |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review
https://doi.org/10.1016/j.artmed.2023.102698 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
The extent to which healthcare professionals perceive AI as fitting with their value system (e.g. whether patient data used for AI is safely managed to protect their privacy) and that of the medical profession |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review
https://doi.org/10.1016/j.artmed.2023.102698 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
None of the above |
|
should ensure to conduct a sub-group analysis based on temporality to better understand how AI acceptability outcomes might vary based on study temporality. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review
https://doi.org/10.1016/j.artmed.2023.102698 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
In preclinical studies, we have shown that such differentiated human embryonic stem cell (hESC)-derived DA neurons can fully reverse motor impairments in experimental models of PD and that the neurons function en par with human fetal DA neurons. |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD
https://doi.org/10.1016/j.stem.2023.08.014 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
The safety study found no treatment-related effects on mortality, body weight, body temperature, organ weight, food consumption, ophthalmological findings, or on the Irwin assessment of behavior. Some non-adverse inter-group variations in hematology and blood chemistry were observed, as well as the appearance of peripheral tumors in both treated and untreated animals that were unrelated to the graft, but likely attributable to the immunodeficient nature of the nude rat model |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD
https://doi.org/10.1016/j.stem.2023.08.014 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|